R 0014/24 (Petition for review) of 06.06.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:R001424.20250606
- Date of decision
- 6 June 2025
- Case number
- R 0014/24
- Petition for review of
- -
- Application number
- 13184864.0
- IPC class
- C12N 9/52
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods for the manufacture of proteolytically processed polypeptides
- Applicant name
- Ipsen Bioinnovation Limited
- Opponent name
- ALLERGAN, INC.
- Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 101(3)(b)European Patent Convention Art 112a(1)European Patent Convention Art 112a(2)(c)European Patent Convention Art 113(1)European Patent Convention Art 114(2)European Patent Convention Art 138European Patent Convention Art 76(1)European Patent Convention R 106European Patent Convention R 107European Patent Convention R 109(2)(a)European Patent Convention R 109(2)(b)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(2)Rules of procedure of the Boards of Appeal Art 15(1)Rules of procedure of the Enlarged Board of Appeal Art 13Rules of procedure of the Enlarged Board of Appeal Art 14(2)
- Keywords
- Petition for review - clearly inadmissible
Petition for review - clearly unallowable
Compliance with Rule 106 EPC - no
Fundamental violation of Article 113(1) EPC - no - Catchword
- -
- Cited cases
- R 0001/08R 0010/09R 0010/11R 0017/11R 0019/11R 0015/12R 0008/13R 0016/13R 0006/17R 0008/17R 0007/21R 0012/21
- Citing cases
- -
Order
For these reasons it is decided that:
The petition for review is unanimously rejected as being clearly inadmissible or unallowable.